News

A UCSF team discover how breast cancer tumors tunnel into neighboring fat cells to trigger fat breakdown in order to feed on ...
UCSF looks back on four ways it pioneered deep brain stimulation with the help of federal funding, helping patients with ...
Scientists discover a protein that gets concentrated in the brain during aging, leading brain connections to wither and ...
The vascular surgery team at UCSF Health recently became the first among University of California medical centers to implant a Barostim device to treat heart failure. The team implanted the device in ...
Two new Pew Latin American fellows, Beatriz De Moraes, PhD, and Lilian Gomes de Oliveira, PhD, will each receive a $30,000 ...
A UCSF team develops a new drug for malaria that could address one of the disease's biggest challenges - the spread of parasites that resist the most commonly-used medications.
The UCSF community is saddened at the passing of former UCSF faculty member William Rutter, PhD, whose collaborative and interdisciplinary research style helped guide the growth and quality of the ...
In one of the largest studies of its kind, researchers identified the U.S. regions where dementia occurs most often.
A first-of-its-kind study tested the safety of psilocybin on patients with mild to moderate Parkinson’s disease and found that patients experienced clinically significant improvements in mood, ...
The FDA has approved an adaptive deep brain stimulation (aDBS) treatment for people with with Parkinson’s disease, making this groundbreaking technology available to people nationwide.
Rates of advanced prostate cancer in California rose significantly in the decade since doctors stopped routinely screening all men. A UCSF study reinforces the need for screening that can identify ...